All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing
This policy note characterizes Canada’s current testing infrastructure and its limitations, which include that it hinders current and future patient access to the best available treatments….
Bluesky Project
Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…
Canadian public insurance plans and delays in patient access to innovative medicines
…public insurance plans face significant delays accessing new medicines. This graph breaks down the sequential approval and listing process, and demonstrates how long it takes Canadians to access innovative medicines….
Research Note: Oncology Clinical Trials: Canada Within the International Context
Clinical trials provide Canadian oncology patients with earlier access to new, innovative cancer treatments. But changes pending to the PMPRB will make the Canadian pharmaceutical market less attractive for investment….
2022 Federal Pre-Budget Consultation
Our industry calls on the federal government to implement measures under the Biomanufacturing and Life Sciences Strategy to build a more vibrant life sciences sector and enhance patients’ access to…